Ron Cohen, President and CEO at ACORDA THERAPEUTICS INC (ACOR), sold 55,000 shares at $36.51 ($2.0M) on 2010-08-05, disclosed to the SEC on 2010-08-09.
Open-market sale of $2.0M ACOR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.85 | 48,217 | $1.7M | 87.5% |
| 2 | $36.51 | 6,783 | $248K | 12.5% |
| Total | $35.93 avg | 55,000 | $2.0M | 100% |
| Filing → |
| ACOR | SELL | 2019-12-04 | $8K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $75K | — | Filing → |
| ACOR | BUY | 2017-06-20 | $339K | — | Filing → |